Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 8/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26540655 | 0.94 | ICMT (0.38) | ICMTEPHX2PDE2APDE10AGPBAR1 | |
| SCHEMBL26538526 | 0.94 | ICMT (0.40) | ICMT | |
| SCHEMBL26533963 | 0.92 | ICMT (0.41) | ICMT | |
| SCHEMBL26529426 | 0.90 | SCD (0.37) | ICMTPDK2DHODHAKR1C3AKR1C2 | |
| SCHEMBL26540818 | 0.90 | ICMT (0.37) | ICMT | |
| SCHEMBL26529328 | 0.90 | ICMT (0.40) | ICMTDHODH | |
| SCHEMBL26538507 | 0.90 | KIF11 (0.39) | ICMTDHODH | |
| SCHEMBL26539889 | 0.90 | ICMT (0.40) | ICMTDHODH | |
| SCHEMBL26540469 | 0.90 | ICMT (0.41) | ICMTGAAATM | |
| SCHEMBL26529373 | 0.89 | ICMT (0.40) | ICMTDHODHPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | ICMT 36/4885EPHX2 443/4885PDE2A 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.